Back to search
Acute Intermittent Porphyria (AIP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Intermittent Porphyria (AIP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Intermittent Porphyria (AIP) trials you may qualify forThe main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria). Aim: Investig…
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pr…
This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porp…
The purpose of this study is to determine if Panhematin is safe and effective for prevention of acute attacks of porphyria. The study aims to provide high qual…
The long term objective of the research is to identify new biomarkers of disease activity in the human acute porphyrias. This pilot study is intended to provide…
This study aims to provide high quality evidence for the effectiveness and safety of hemin (PanhematinTM , Recordati) for treatment of acute attacks of porphyri…